Jazz Pharmaceuticals plc — Director's Dealing 2011

Mar 11, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JAZZ PHARMACEUTICALS INC (JAZZ)
CIK: 0001232524
Period of Report: 2011-03-10

Reporting Person: Wissel Janne LT (SVP, Chief Regulatory Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-03-10	Option (right to buy)	$27.46	A	35000	Acquired	2021-03-09	Common Stock (35000)	Direct

Footnotes

F1: The options vest over four years measured from the vesting commencement date, March 1, 2011, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter.